放射性核素骨显像中软组织异常摄取骨显像剂的临床意义

目的 探讨放射性核索骨显像中软组织异常摄取骨显像剂的临床意义。方法 受检者常规行^99Tc^m-亚甲基二膦酸盐（MDP）骨显像，对1173例骨显像中软组织异常摄取骨显像荆进行分析。结果 1173例骨显像中软组织异常摄取骨显像剂39例（3．32％）。其中肺摄取10例；肝摄取9例；乳腺摄取7例；肌肉软组织及皮下摄取4例；胸膜摄取3例；腹膜摄取2例；脾摄取2例；胃癌术后残余灶及结肠癌摄取各1例。结论 多种原因均可致骨外软组织异常摄取骨显像剂．应结合临床及其他检查综合判断。

Clinical significance about soft tissue abnormal uptake skeletal imaging agent in radionuclide bone imaging

Objective To discuss the the clinical significance about soft tissue abnormal uptake skeletal imaging agent in radionuclide bone imaging. Methods Subjects received 99Tcm-methene bisphosphonates(MDP) bone imaging in routine method, to analyze the 1173 cases whose soft tissue abnormal uptook skeletal imaging agent in bone imaging. Results There were 39 (3.32%) cases whose soft tissue abnormal uptook skeletal imaging agent in bone imaging among the 1173 subjects. Among the 39 cases, there were 10 lung uptake cases; 9 hepatic uptake cases; 7 lacteal gland uptake cases; 4 muscle soft tissue and hypoderma uptake cases; 3 membrane pleuralis uptake cases; 2 abdominal membrane uptake cases; 2 spleen uptake cases; 1 postoperative residual of gastric cancer uptake cases; 1 postoperative residual of colon carcinoma uptake cases. Conclusion The phenomenon of ectosteal soft tissue abnormal uptake skeletal imaging agent can be induced by a variety of causes, we should combine clinical symptom and other checks to make decision.